chrisvoncsefalvay/vaers-outcomes huggingface dataset:
After leaving the office pt failed with brief LOC and low BP. Pt was brought back to examining room and monitored for 1 hr until symptom free.
As I was injecting the Varicella into the patient's left thigh (subcutaneously), the patient moved his leg slightly and while some of the vaccine went into his leg, he was not given a full dose. Vaccine administration error; should have held patient's leg more tightly.
Headache, Myalgia, chills, tingling on body, flush, loss of appetite Narrative:  Self care at Home- took Ipuprofen. Lasted 24 hrs and resolved.  Other Relevant History:
Patient received expired vaccine; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) in a 44-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009C21A) for COVID-19 vaccination.     Previously administered products included for COVID-19 vaccination: PFIZER BIONTECH COVID-19 VACCINE (1st Dose) on 24-Mar-2021 and PFIZER BIONTECH COVID-19 VACCINE (Second dose) on 14-Apr-2021. Past adverse reactions to the above products included No adverse event with PFIZER BIONTECH COVID-19 VACCINE and PFIZER BIONTECH COVID-19 VACCINE.    On 10-Dec-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Dec-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On 10-Dec-2021, EXPIRED PRODUCT ADMINISTERED (Patient received expired vaccine) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment information was reported.
Patient advised nurse that she was feeling her arms and legs tingle. When I arrived she was "sweaty". She stated that she was dizzy and her lips tingled. SOB. No further treatment given.
Vacinated on 22Jan2021 at 3pmgot dizzy, nausea and vomitted on 23Jan2021 at 4.pm Got Dizzy, nausea and vomited again on 29Jan2021 at 4 pm; Vacinated on 22Jan2021 at 3pmgot dizzy, nausea and vomitted on 23Jan2021 at 4.pm Got Dizzy, nausea and vomited again on 29Jan2021 at 4 pm; Vacinated on 22Jan2021 at 3pmgot dizzy, nausea and vomitted on 23Jan2021 at 4.pm Got Dizzy, nausea and vomited again on 29Jan2021 at 4 pm; This is a spontaneous report from a non-contactable consumer or other non hcp (patient).   A male patient (at the age 76, unit was unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9261), via an unspecified route of administration, on 22Jan2021at 15:00 as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. It was unknown whether the patient had covid prior to vaccination. On 22Jan2021 at 16:00, the patient got dizzy, nausea and vomited and on 29Jan2021 at 16:00, the patient again got dizzy, nausea and vomited. No treatment was given for the adverse events. Patient was not tested for covid post vaccination. At the time of this report event outcome was unknown.   No follow-up attempts are possible. No further information is expected.
Nausea, headache, vertigo started 15 minutes after receiving vaccine. 24 hours later developed arm pain, generalized muscle aches. 36 hours after developed chills, fever 102.5, headache, fatigue 48 hours fatigue, muscle aches present but less fatigue lasted 5 days
after their first and second dose, their injection arm was warm; patient  also experienced a little discomfort; Body ache; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE WARMTH (after their first and second dose, their injection arm was warm), DISCOMFORT (patient  also experienced a little discomfort) and MYALGIA (Body ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 029K20A and 039K20A) for COVID-19 vaccination.     The patient's past medical history included Thyroidectomy. Concurrent medical conditions included Diabetes.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE WARMTH (after their first and second dose, their injection arm was warm), DISCOMFORT (patient  also experienced a little discomfort) and MYALGIA (Body ache). At the time of the report, VACCINATION SITE WARMTH (after their first and second dose, their injection arm was warm), DISCOMFORT (patient  also experienced a little discomfort) and MYALGIA (Body ache) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported  No Treatment medications reported   This case was linked to MOD-2021-318331, MOD-2021-318415 (Patient Link).
Pt returned to office approximately 1 hour after vaccines. Had generalized urticarial eruption (hives), no difficulty breathing. Benadryl given.
No adverse event. She had already got a flu shot 9/30/23 at her doctor's office. She asked for flu shot but wanted covid shot. We eill give her covid shot
Fever, chills, body aches 24 hours.  Continues 72 hours later to have swollen axillary lymph right arm.  Pain at injection site.
This spontaneous report was received from a medical assistant and refers to an unspecified amount of patients of unknown age and genders. No medical history, concurrent conditions or concomitant therapies were reported. On an unknown dates (since July 2014 till at least the end of January 2015), the patients were vaccinated with improperly stored doses of adult and pediatric RECOMBIVAX HB (lot #, expiration date, dose, route of administration and anatomical location were not reported). No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
leg pain, limping over next several days fever over night and into next day lethargic odd behavior such as "everyone hates me", "no one likes me" rash on lower back vomiting about 10 days later  coughing since injection Treatments: cold compress, nutritional supplements for detoxing such as cilantro or Chlorophyll, Tylenol for fever. hydration for vomiting and rest.  Epsom salt bath and icing for leg soreness Outcomes: all aside from coughing have resolved.  odd behavior is being monitored
Patient was diagnosed with perimyocarditis on 6/1 at medical facility. Prior to that he had been having 1 week of general malaise and fatigue with one day of fever and substernal chest pain.
Pain, redness, swelling, itching, muscle body aches, bruise at injection site.
HPV and Hepatitis A vaccines. Patient was awake and responsive during episode, was pallid in color and diaphoretic. POCT glucose taken as well as automatic blood pressure. Patient nauseous without vomiting. Patient was given ice pack, water, and apple juice. After laying supine with legs propped on chair for approximately 7 minutes, patient felt well enough to transfer to wheelchair with assistance. This writer brought patient back to exam room to lay on bed. At roughly 12:00 pm, Patient given Ondansetron 4mg disintegrating tablet by MD for nausea. At roughly 12:05pm, patient endorsed feeling back to baseline, patient discharged from clinic by Dr..
Rash around neck; fatigue; hip replacement; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 04-May-2021 and was forwarded to Moderna on 04-May-2021.    This spontaneous case was reported by a physician and describes the occurrence of HIP ARTHROPLASTY (hip replacement) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) for Plaque psoriasis.    No Medical History information was reported.   On 05-Jan-2021, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 15-Dec-2020, the patient experienced HIP ARTHROPLASTY (hip replacement) (seriousness criterion medically significant) and FATIGUE (fatigue). On an unknown date, the patient experienced RASH (Rash around neck). At the time of the report, HIP ARTHROPLASTY (hip replacement) had resolved and RASH (Rash around neck) and FATIGUE (fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   patient was taking Humira medication but stopped in 2022 and restarted on 05-JAN-2021. No treatment information was provided.   there is no reasonable possibility that the events of hip replacement surgery, after First dose of covid vaccine developed rash around neck and after second dose of covid vaccine patient was fatigue are related to humira (adalimumab); Sender's Comments: Based on reporter's causality the hip replacement event is assessed as unlikely related to mRNA-1273, while fatigue and rash events are possibly related to mRNA-1273.
Narrative:  COVID infection following COVID vaccine series 03/19/2021, Pfizer, dose #1 04/12/2021, Pfizer, dose #2 03/06/2021 outside hospitalization dx: nephrolithiasis, UTI, calculus of kidney & ureter, hydronephrosis with obstruction callus LOS: 3 days 03/13/2021 outside hospitalization dx renal colic LOS: 1 day 03/29/2021 outside hospitalization dx bilat ureteroscopy, laser lithotripsy& indwelling double j ureteral stent exchange 07/07/2021 outside hospitalization dx complicated UTI LOS: 1 day 08/03/2021 ED admission: pt cc: flank pain, SOB, chronic cough, chest pain, abdominal pain, nausea, exposure: unknown 08/4/2021 COVID swab, result: detected 08/4/2021DVT while in the hospital for Covid19 08/4/2021 Troponin I result: <0.016 08/4/2021 COVID swab result: detected 08/4/2021 DDIMER result: 3.71 08/4/2021 PT/ APTT/ INR 14.7/ 26.4/ 1.31 08/4/2021 Amto-Xa Unfractionated Heparin <0.04 08/4/2021 Fibrinogen result: 491 08/4/2021 ct abd/pelvis impression: Multiple nonobstructing intrarenal stones. No obstructing or ureteral stones. Groundglass in the lung bases in keeping with hazy opacities demonstrated on recent chest radiograph, likely infectious. 08/4/2021 CXR impression: Multifocal pneumonia. The appearance can be seen with viral pneumonia as an atypical pneumonia is the correct clinical setting. 08/5/2021 ESR result: 53 08/5/2021 fibrinogen/ DDMER result: 459/ 0.69 08/6/2021 ESR result: 39 08/6/2021 fibrinogen/ DDMER result: 378 /1.18 08/7/2021 ESR result: 35 08/7/2021 fibrinogen/ DDMER result: 365/ 3.30 08/8/2021 ESR result: 20 08/8/2021 fibrinogen/ DDMER result: 300/ 5.07 08/9/2021 ESR result: 11 08/9/2021 fibrinogen/ DDMER result: 261/ 7.28 08/10/2021 ESR result: 13 08/10/2021 fibrinogen/ DDMER result: 261/ 6.21 08/10/2021 PT/ INR result: 12.2/ 1.09 08/10/2021 US Doppler bilat lower ext result: Nonocclusive but mobile thrombus within the proximal right popliteal vein 08/11/2021 PT/ INR result: 14.2/ 1.27 08/16/2021 PT/ INR result: 80.2/ 7.16 08/24/2021 PT/ INR result: 24.8/ 2.21 09/2/2021 PT/INR result: 24.9 /2.22
WITHIN 3 HOURS OF SHOT:  LETHARGY, HEAVINESS IN MUSCLES, FUNNY TASTE IN MOUTH,  NEXT MORNING (18 HOURS AFTERE SHOT) PAIN/SORENESS AT INJECTION SITE AND IN UPPER ARM, DIGESTIVE DISCOMFORT
Redness, warmth, itching, wheal at injection site. Treated with XYZAL 5mg daily.
Red raised rash over trunk of body.  High fever (102.5) in early September for almost a week, followed by joint pain moving throughout body. Rash has continued to present and itches daily. Hair loss, skin flaking, flu-like symptoms w/ high fever in March followed by a 2 weeks of a cold.  Rash and itching, and joint pain continues to present.
No additional AEs were reported; The healthcare worker is reporting that a patient received improperly stored PROQUAD.  Diluent was not involved in the temperature excursion.   No additional AEs were reported, no further information provided.  Names of vaccines involved (including l; This spontaneous report was received from Other Health Professional and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant medications were not reported  On 15-DEC-2022, the patient was vaccinated with an improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (rHA) (PROQUAD) subcutaneous injection, 1 dose, lot #W023866, expiration date: 24-JAN-2024, administered for prophylaxis (strength, and route of administration were not provided). The vaccine was reconstituted using a properly stored sterile diluent (MERCK STERILE DILUENT). The vaccine underwent a temperature excursion of 19.3 degrees Fahrenheit (F) for a period of 2 hours and 30 minutes. The vaccine did not undergo any previous temperature excursion. The heath care worker reported that the patient did not experience any adverse event.
Information has been received from a registered nurse concerning a 33 year female with a sulfonamide allergy who in 2005 was vaccinated with her first dose of RECOMBIVAX HB, and developed a rash over her entire body. It is unknown if the patient will receive the second dose of RECOMBIVAX HB. Unspecified medical attention was sought. The patient was considered recovered at the time of this report. There was no product quality complaint. Additional information has been requested.
Rec'd MMR and Hep B. 2 hours later developed localized itching at injection site along with SOB and throat tightness. Sent to ER. Given muscle relaxer and advised to seek eval with allergist.
After getting the vaccine I had a very severe cold and I thought it was Covid but it was not. I had itching starting at the top of my body and going down. I did not pay too much attention to it. As the days passed by the symptoms became worse. 2 weeks ago I shaved my legs and I had some red spots on my legs and they got infected so I went to the doctor and they told me that I had folliculitis on my left leg. They gave me Cephalexin and Benadryl. I completed my Cephalexin treatment but now I noticed I have those spots on my right arm, the itching is horrible. Today I went to the doctor and they could not see me because my doctor is out of town.
Fever onset 1/2 hr post vax, 100F with use of Tylenol. Unconsolable crying x 4 days- would cry self to sleep, would eat but continue to cry.
Headache, Body Aches like flu, queasy stomach, hot/cold flashes.
a patient faints after a G9 vaccination; This spontaneous report was received from a pharmacist via a company representative referring to a patient of unknown age and gender. Information regarding the patient's pertinent medical history, historical drugs, concurrent conditions, concomitant therapies, and previous drug reactions or allergies was not reported.      On an unknown date, the patient was vaccinated with hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for immunisation (dose, vaccination scheme frequency, route of administration, anatomical site of vaccination, lot number and expiration date were not reported).         On an unknown date, the patient fainted after the vaccination (syncope). The outcome of syncope was unknown.        Upon internal review, the event syncope was determined to be medically significant.      This is a non-valid case due to lack of patient's identifiers.
This case described the occurrence of liver damage in an adult male pt who received hepatitis B vaccine recombinant (Engerix-B) for prophylaxis.  This report was received from the pt and has not been verified by a physician or other health care professional.  The pt's medical history, concurrent conditions, and concurrent medications were not reported.  The pt stated, "I have records of my lab test done only a year before the vaccine shots started and my liver, and functions, were all normal."  On 05/25/01 the pt reportedly received the 3rd dose of Engerix-B.  At an unknown time post-immunization, in 2001, the pt reported that he experienced "liver damage" with aspartate aminotransferase concentrations twice the reference range and alanine aminotransferase concentrations four times the reference range.  The pt stated that he received medical attention.  He reported that as of 03/20/03, the increased aspartate aminotransferase and alanine aminotransferase concentrations persisted, and the liver damage was "permanent".  The pt declined to provide additional information, and declined to grant authorization to GSK to contact his health care providers.
Patient had a headache and sore arm for 6 days.  Her lower left arm broke out with a rash the same day and is still present.  She did take a Benadryl for allergy related issues unrelated to the vaccine.
7 days after (Wednesday, January 27) receiving the vaccine, I developed a small itchy hive at the injection site. Considered it was a mosquito bite but woke up the following day (Thursday) with the area swollen, red, and hot to the touch.  I also had a stomach ache so I took Tylenol which did not help.  Friday, I took ibuprofen  and the redness and swelling subsided but the heat remained until the evening of Sunday, January 21 when I started having an anxiety attack and noticed a red ring/rash around the injection site.  I took benadryl but it's still there.  I read that people are calling it "Covid arm."  It's not itchy, just a raised red circle/square about 5 inches in diameter around the injection site.  It is still very hot to the touch.  Besides this and severe anxiety brought on by it, I've had no other symptoms.
This case was reported by a healthcare professional and described the occurrence of generalized rash in a 42-year-old female subjected who was vaccinated with ENGERIX B adult (Glaxosmithkline). The subject had experienced no adverse events following previous vaccinations. On 14 April 2009 in the morning, the subject received 1st dose of ENGERIX B adult (unknown route, unknown deltoid). On 15 April 2009, approximately 1 day after vaccination with ENGERIX B adult, the subject experienced generalized rash. At the time of reporting the outcome of the event was unspecified. The healthcare professional considered the event was possibly related to vaccination with ENGERIX B adult.
Client returned to the IZ clinic around 15:10 with MOC, approximately 1-hour after receiving the following vaccines: Tdap, MCV4, HPV4, and Flumist. Client presented with 2 visible hives in the RUE (site where HPV4 was administered)  1 on forearm and one on wrist; client denied shortness of breath, trouble breathing, swelling of tongue or throat. Client was given one 25mg Benadryl tablet while in clinic. MOC educated to immediately take client to the ED if any breathing difficulties such as swelling of tongue or throat or SOB present.
Lips were red and sunburned like with pain.   Following day, fever blisters broke out.  (common when my lips get sunburned).   Treated with Carmex at onset and they went away in a couple days, fairly quickly.
Had the vaccine around 10:45 am. Did a short workout like normal. Went to lunch around 12:30. Had odd shocking tooth pain. Tooth persisted without being influenced by hot or cold food or fluid. A couple hours later, it felt like I had a long hair bothering my arms, this was intermittent. It persisted for a while. I felt a hair again and when I brushed  the vein on top of my right mid forearm,  I felt a tingling sensation from my wrist to my elbow going up my vein (like a reverberating guitar string). This didn't last long but very odd. Later in the evening as I was relaxing on the couch, my left arm would easily fall asleep and I constantly had to adjust and move around. I started to get a pain in my left arm pit under my shoulder, close to my left breast. This lasted for about 30 minutes. Again, adjusting my body position to alleviate discomfort. I would feel better and lay back down on my right side (as left side was sore from the vaccine). Pain in armpit was expanding towards my heart and chest while still having sensitivity issues. I drank a lot of water but did not take aspirin. I was able to fall asleep and wake up the next day. Currently (08/31/2021), I do not have these sensations but have a mild headache. I will be adding small dosage of baby aspirin each day to prevent possible blood clots.
Information has been received from a registered nurse concerning a male who was vaccinated with one dose of MMR II. The patient had low titers for measles antibodies. The vaccine was administered at a different facility and the patient did not remember when he received it. The patient had titers test performed. The patient sought medical attention by coming to health department. Follow-up information was received reporting that they had no information regarding the patient and that he "apparently had the MMR II some time ago" (date, dose and lot # not reported). No further information is available.
After 9-10 days, he developed a red raised lump. The area stayed red for about 1 week. It was the same place were he received his varicella vaccine.
SEVERE SINUS HEADACHE; ACHEY; DRY COUGH; WINDED; SORE THROAT; SINUS CONGESTION; FEVERISH; HEADACHE; NAUSEA; DIARRHEA; This spontaneous report received from a patient concerned a White, Not Hispanic or Latino male of unspecified age. The patient's height, and weight were not reported. The patient's concurrent conditions included seasonal allergy. The patient received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of admin not reported, batch number: 204A21A, expiry: unknown) dose was not reported, 1 total administered on 05-JUN-2021 to left arm for prophylactic vaccination. No concomitant medications were reported. On an unspecified date, the patient experienced severe sinus headache, achey, dry cough, winded, sore throat, sinus congestion, feverish, headache, nausea, and diarrhea. (dose number in series 1). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from severe sinus headache, achey, and feverish, had not recovered from headache, diarrhea, nausea, dry cough, sore throat, and sinus congestion, and the outcome of winded was not reported. The patient received additionally booster BNT 162 (Pfizer) vaccine (dose number in series 2) (Form of admin not reported, intramuscular, batch number: Unknown, expiry: unknown) dose was not reported, administered on 18-DEC-2021 for prophylactic vaccination. It was unknown whether patient had any adverse event following vaccination with BNT162 (Pfizer). (Dose number in series 2). This report was non-serious.
Client received J&J vaccine on 3-5-2021 then recevied Pfizer vaccine on 10-02-2021.
One day after flu shot patient began feeling weak and ill.  One week later he is hospitalized with a pneumonia and pneumothorax.  Not getting better yet. Kidney function deteriorated.  May need dialysis.
Pt got vaccine that wasn't diluted enough. Suspect volume of saline was less than required 1.3ml.  Pt. was contacted and had no side effects.